Luke Sergott
Stock Analyst at Barclays
(2.25)
# 2,682
Out of 4,886 analysts
293
Total ratings
43.64%
Success rate
-4.97%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintains: Equal-Weight | $2 → $1.5 | $1.50 | - | 5 | Jun 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Equal-Weight | $475 → $450 | $426.17 | +5.59% | 25 | Jun 24, 2025 | |
| SHC Sotera Health Company | Maintains: Overweight | $15 → $13 | $11.59 | +12.21% | 21 | Jun 24, 2025 | |
| ILMN Illumina | Maintains: Underweight | $77 → $85 | $99.27 | -14.37% | 18 | Jun 24, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $75 → $65 | $53.54 | +21.40% | 5 | Jun 24, 2025 | |
| DHR Danaher | Maintains: Overweight | $215 → $225 | $200.68 | +12.12% | 40 | Jun 24, 2025 | |
| A Agilent Technologies | Maintains: Equal-Weight | $115 → $125 | $121.01 | +3.30% | 9 | Jun 24, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $12 → $13 | $12.25 | +6.12% | 12 | Jun 24, 2025 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $245 | $220.48 | +11.12% | 1 | Jun 24, 2025 | |
| RGEN Repligen | Initiates: Overweight | $150 | $128.56 | +16.68% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $47.85 | +14.94% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,206.53 | +9.82% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $300 | $322.50 | -6.98% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $5 | $4.79 | +4.38% | 10 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $190 | $158.48 | +19.89% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $11.40 | +22.81% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $155 | $158.39 | -2.14% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $46 | $42.36 | +8.59% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $165 | $164.47 | +0.32% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $151.58 | +2.26% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $50.82 | +18.06% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $18 → $15 | $13.75 | +9.09% | 24 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $347.78 | +0.64% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $37.00 | +21.62% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $100.66 | +9.28% | 9 | Apr 10, 2025 |
Pacific Biosciences of California
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.50
Upside: -
Thermo Fisher Scientific
Jun 24, 2025
Maintains: Equal-Weight
Price Target: $475 → $450
Current: $426.17
Upside: +5.59%
Sotera Health Company
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $11.59
Upside: +12.21%
Illumina
Jun 24, 2025
Maintains: Underweight
Price Target: $77 → $85
Current: $99.27
Upside: -14.37%
Exact Sciences
Jun 24, 2025
Maintains: Overweight
Price Target: $75 → $65
Current: $53.54
Upside: +21.40%
Danaher
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $200.68
Upside: +12.12%
Agilent Technologies
Jun 24, 2025
Maintains: Equal-Weight
Price Target: $115 → $125
Current: $121.01
Upside: +3.30%
10x Genomics
Jun 24, 2025
Maintains: Overweight
Price Target: $12 → $13
Current: $12.25
Upside: +6.12%
West Pharmaceutical Services
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $220.48
Upside: +11.12%
Repligen
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $128.56
Upside: +16.68%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $47.85
Upside: +14.94%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,206.53
Upside: +9.82%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $300
Current: $322.50
Upside: -6.98%
May 13, 2025
Maintains: Underweight
Price Target: $6 → $5
Current: $4.79
Upside: +4.38%
May 9, 2025
Maintains: Overweight
Price Target: $160 → $190
Current: $158.48
Upside: +19.89%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.40
Upside: +22.81%
May 8, 2025
Maintains: Equal-Weight
Price Target: $145 → $155
Current: $158.39
Upside: -2.14%
May 8, 2025
Maintains: Overweight
Price Target: $50 → $46
Current: $42.36
Upside: +8.59%
May 7, 2025
Maintains: Equal-Weight
Price Target: $170 → $165
Current: $164.47
Upside: +0.32%
May 2, 2025
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $151.58
Upside: +2.26%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $50.82
Upside: +18.06%
Apr 28, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $13.75
Upside: +9.09%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $347.78
Upside: +0.64%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $37.00
Upside: +21.62%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $100.66
Upside: +9.28%